Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells.
about
HSP70 protects BCL2L12 and BCL2L12A from N-terminal ubiquitination-mediated proteasomal degradationCeramide Synthase 6 Is a Novel Target of Methotrexate Mediating Its Antiproliferative Effect in a p53-Dependent MannerBCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma.The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic LeukemiasCisplatin downregulates BCL2L12, a novel apoptosis-related gene, in glioblastoma cells.Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol.Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol.Effect of bleomycin and cisplatin on the expression profile of SRA1, a novel member of pre-mRNA splicing factors, in HL-60 human promyelocytic leukemia cells.
P2860
Q24317340-ACBF4FC9-8771-45E4-8397-13787F2ADBCAQ28552611-8DF171B9-2DE8-4DDB-834E-7912DCB1D104Q34699520-B213151E-ABDB-4E5D-855B-ACB35E067577Q35584788-2F1ADEF0-3F97-4EAA-AB02-74E5C636FBBFQ38439738-9E27E9A5-C6C6-4134-A97B-64190B056A5DQ39147197-AF747A35-5906-4782-A90A-C93FDFBFC18FQ39413532-3E87D459-34D0-40D9-A8C8-49CEC8F9A052Q39941320-7842CF82-5E36-459F-8CA0-AEE70BE59997Q50466750-F93EF678-8C9A-41E2-B6C9-07BD15344E13
P2860
Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Topotecan and methotrexate alt ...... L2L12 in leukemic HL-60 cells.
@en
type
label
Topotecan and methotrexate alt ...... L2L12 in leukemic HL-60 cells.
@en
prefLabel
Topotecan and methotrexate alt ...... L2L12 in leukemic HL-60 cells.
@en
P2860
P356
P1433
P1476
Topotecan and methotrexate alt ...... L2L12 in leukemic HL-60 cells.
@en
P2093
Kostas V Floros
P2860
P304
P356
10.1515/BC.2006.203
P577
2006-12-01T00:00:00Z